AGL 40.00 No Change ▼ 0.00 (0%)
AIRLINK 129.06 Decreased By ▼ -0.47 (-0.36%)
BOP 6.75 Increased By ▲ 0.07 (1.05%)
CNERGY 4.49 Decreased By ▼ -0.14 (-3.02%)
DCL 8.55 Decreased By ▼ -0.39 (-4.36%)
DFML 40.82 Decreased By ▼ -0.87 (-2.09%)
DGKC 80.96 Decreased By ▼ -2.81 (-3.35%)
FCCL 32.77 No Change ▼ 0.00 (0%)
FFBL 74.43 Decreased By ▼ -1.04 (-1.38%)
FFL 11.74 Increased By ▲ 0.27 (2.35%)
HUBC 109.58 Decreased By ▼ -0.97 (-0.88%)
HUMNL 13.75 Decreased By ▼ -0.81 (-5.56%)
KEL 5.31 Decreased By ▼ -0.08 (-1.48%)
KOSM 7.72 Decreased By ▼ -0.68 (-8.1%)
MLCF 38.60 Decreased By ▼ -1.19 (-2.99%)
NBP 63.51 Increased By ▲ 3.22 (5.34%)
OGDC 194.69 Decreased By ▼ -4.97 (-2.49%)
PAEL 25.71 Decreased By ▼ -0.94 (-3.53%)
PIBTL 7.39 Decreased By ▼ -0.27 (-3.52%)
PPL 155.45 Decreased By ▼ -2.47 (-1.56%)
PRL 25.79 Decreased By ▼ -0.94 (-3.52%)
PTC 17.50 Decreased By ▼ -0.96 (-5.2%)
SEARL 78.65 Decreased By ▼ -3.79 (-4.6%)
TELE 7.86 Decreased By ▼ -0.45 (-5.42%)
TOMCL 33.73 Decreased By ▼ -0.78 (-2.26%)
TPLP 8.40 Decreased By ▼ -0.66 (-7.28%)
TREET 16.27 Decreased By ▼ -1.20 (-6.87%)
TRG 58.22 Decreased By ▼ -3.10 (-5.06%)
UNITY 27.49 Increased By ▲ 0.06 (0.22%)
WTL 1.39 Increased By ▲ 0.01 (0.72%)
BR100 10,445 Increased By 38.5 (0.37%)
BR30 31,189 Decreased By -523.9 (-1.65%)
KSE100 97,798 Increased By 469.8 (0.48%)
KSE30 30,481 Increased By 288.3 (0.95%)
Technology

American company brings dead people back to life

Bioquark, a life science company, hopes to bring people declared as clinically brain-dead back to life through stem
Published June 8, 2017

Bioquark, a life science company, hopes to bring people declared as clinically brain-dead back to life through stem cells. Trials will be initiating soon.

With rapid increases in technology from human head transplants to reversing symptoms of ageing, researchers are surely setting high goals.

With their latest discovery of reversing death, the Philadelphia-based biotech company is supposed to work on its project by the end of this year.

Though the trials were expected to begin in 2016 in India, the regulators had it shut down. Now, the researchers plan on conducting considerably similar plan and will enroll 20 patients who will go through different treatments.

With the stem cells being cut off from the patient’s own fat or blood, a stem cell injection will be given to the patients first. Then, a protein blend will be injected into the spinal cord which is supposed to advance new neuron growth. With the intention of promoting neuron communications, the laser therapy and nerve stimulation will be conducted next for another 15 days, reported Futurism.

In the mean time, the researchers will examine behavior and EEGs both to see any indications of the treatment causing any alterations.

However, a few researchers have raised questions regarding the informed consent from the patients. They question about how will the researchers go forth with their trails and how would they complete the paperwork considering that the patients is already brain dead?

Another question raised was what if the brain activity came back and what would be the patient’s mental state? And what could be the possible outcomes other than extreme brain damage?

According to Science Alert, back in 2016, Stat News reported neurologist Ariane Lewis and bioethicist Arthur Caplan stated in Critical Care the trail as “dubious”, “has no scientific foundation” and suffers from an “at best, ethically questionable, and at worst, outright unethical nature”.

Researchers also doubt the company’s techniques and believe “there is no way this technique could work on someone who is brain-dead”.

Researchers claim, “The technique relies on there being a functional brain stem – one of the structures that most motor neurons go through before connecting with the cortex proper. If there's no functional brain stem, then it can't work.”

Copyright Business Recorder, 2017

Comments

Comments are closed.